Table 1.
Discrepancies between reported and documented medications prescribed for the management of liver-related complications
| Number of liver medicationsa | Patient reported but not documented in medical record | Documented in medical record but not reported by patient | Concordant medications | Proportion (%) discordant records within drug-disease category |
|---|---|---|---|---|
| Diuretics n = 16 | 1 | 2 | 13 | 18.8 % |
| Propranolol n = 9 | 0 | 0 | 9 | 0.0 % |
| Cholecalciferol n = 8 | 4 | 0 | 4 | 50.0 % |
| PPIs n = 7 | 2 | 1 | 4 | 42.9 % |
| Thiamine n = 6 | 1 | 0 | 5 | 16.7 % |
| Lactulose n = 5 | 0 | 3 | 2 | 60.0 % |
| Antivirals n = 4 | 0 | 0 | 4 | 0.0 % |
| Other n = 9b | 3 | 1 | 5 | 44.4 % |
aExcluding 6 liver medications which were only documented in ELMs (n = 1 for thiamine, rifaximin, PPI, lactulose, cholecalciferol, spironolactone)
bRifaximin, spontaneous bacterial peritonitis prophylaxis, ursodeoxecholic acid, other vitamins and protein supplements prescribed for complications of cirrhosis